Adaptimmune Therapeutics plc Cash Flow Quality Index
Adaptimmune Therapeutics plc cash flow quality index. Adaptimmune Therapeutics plc (473A) has a Cash Flow Quality Index of 0.68x as of June 2024. Operating cash flow of €47.40 Million is below net income of €69.52 Million, suggesting accrual-heavy earnings not yet converted to cash. See 473A free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Adaptimmune Therapeutics plc Cash Flow Quality Index by Year (None–None)
Adaptimmune Therapeutics plc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Adaptimmune Therapeutics plc. For the full cash flow conversion analysis, see Adaptimmune Therapeutics plc (473A) cash conversion ratio.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|